Marshall Wace North America’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Marshall Wace North America’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-34,252	Closed	-$528K	–	1893
2018 Q4	$528K	Buy	+34,252	New	+$702K	0.01%	765
2018 Q3	–	Sell	-449,276	Closed	-$10.9M	–	1360
2018 Q2	$10.9M	Buy	+449,276	New	+$9.16M	0.06%	317
2013 Q3	–	Sell	-98,119	Closed	-$3.85M	–	705
2013 Q2	$3.85M	Buy	+98,119	New	+$3.82M	0.3%	113

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace North America's TEVA Position: Q1 2019 in Review

Marshall Wace North America sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 34,252 shares — an estimated $528K sold.

Marshall Wace North America first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $10.9M in Q2 2018. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

Marshall Wace North America reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
Marshall Wace North America sold 34,252 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $528K.
Marshall Wace North America first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 3 quarters.
Marshall Wace North America's Teva Pharmaceutical Industries Limited position peaked at $10.9M in Q2 2018.
522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.